LYRA 250516 0.50P(LYRA250516P500) Stock Price Today

US OptionsDetailed Quotes

LYRA250516P500

Watchlist

0.40
0.000.00%

15min DelayClose May 9 14:43 ET

0.00High0.00Low

Intraday

5D
Daily

News

BTIG Initiates Lyra Therapeutics(LYRA.US) With Hold Rating
Moomoo NewsMay 8 12:31 ET · Ratings
BTIG Keeps Their Hold Rating on Lyra Therapeutics (LYRA)
TipRanksMay 8 06:04 ET · Ratings
Analysts Offer Insights on Healthcare Companies: Inogen (INGN) and Lyra Therapeutics (LYRA)
TipRanksMay 8 06:04 ET · Ratings
Lyra Therapeutics Announces It Will Present 52-Week Extension Stage Results For ENLIGHTEN 1 Phase 3 Study For LYR-210 For The Treatment of Chronic Rhinosinusitis At COSM May 14-18 2025 In New Orleans
BenzingaMay 7 07:09 ET
Lyra Therapeutics GAAP EPS of -$0.13 Beats by $0.01, Revenue of $0.18M Beats by $0.02M
Seeking AlphaMay 6 17:13 ET
Lyra Therapeutics | 10-Q: Q1 2025 Earnings Report
SECMay 6 16:17 ET · Announcements

Comments

FattyChick

May 7 21:59

$Lyra Therapeutics (LYRA.US)$ Nice back to back pump on biotech tickers.

Teddy123

May 7 19:32

Lyra Therapeutics to Present 52-week Extension Stage Results for ENLIGHTEN 1 Phase 3 Study for LYR-210 for the Treatment of Chronic Rhinosinusitis at COSM 2025

$Lyra Therapeutics (LYRA.US)$
Lyra Therapeutics to Present 52-week Extension Stage Results for ENLIGHTEN 1 Phase 3 Study for LYR-210 for the Treatment of Chronic Rhinosinusitis at COSM 2025

Trytosaveabit

May 7 04:13

Make a note! R/S should be before Data?

$Lyra Therapeutics (LYRA.US)$ Upcoming milestones for ongoing ENLIGHTEN pivotal program of LYR-210 in CRS
•Topline results from the ENLIGHTEN 2 pivotal Phase 3 clinical trial of LYR‑210 in CRS patients are expected in Q2 2025.•We expect an additional ~30 polyp patients in the ENLIGHTEN 2 trial, which combined with the 35 polyp patients in the ENLIGHTEN 1 trial, would result in a total of ~65 polyp patients in the ENLIGHTEN program.
The ENLIGHTEN program cons...

Midoo EGY

Apr 12 03:34

$Lyra Therapeutics (LYRA.US)$ what? anynews?

Frankiy

Apr 5 06:07

$Lyra Therapeutics (LYRA.US)$ 0.1206 should see a bounce next week imo